http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4337259-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5deddb47ccaab1d4da2aacc344dd8717 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-32 |
| filingDate | 1981-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1982-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c52c76da2649a0e1b84da579505ca3 |
| publicationDate | 1982-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4337259-A |
| titleOfInvention | Pyridine derivatives |
| abstract | The invention relates to a pharmaceutical composition comprising an anti-ulcer effective amount of a compound of formula I <IMAGE> wherein R represents hydrogen, lower alkyl, phenyl, halophenyl, loweralkylphenyl, loweralkoxyphenyl, or aralkyl of 7 to 12 carbon atoms, R1 represents hydrogen or lower alkoxy, R2 represents hydrogen, chlorine or trifluoromethyl and n is 1 or 2, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable carrier. A method of treating ulcers or hypersecretion in a mammal which comprises administering a compound of formula I is also disclosed. Some compounds of formula I are novel and within the scope of the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4631287-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4839353-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4394509-A |
| priorityDate | 1980-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.